Compare TNXP & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNXP | ASYS |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | 81 | 264 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 242.0M |
| IPO Year | N/A | N/A |
| Metric | TNXP | ASYS |
|---|---|---|
| Price | $17.08 | $16.62 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $70.00 | N/A |
| AVG Volume (30 Days) | ★ 455.8K | 448.4K |
| Earning Date | 03-17-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,299,000.00 | ★ $79,364,000.00 |
| Revenue This Year | $7.00 | $2.82 |
| Revenue Next Year | $718.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.76 | $3.20 |
| 52 Week High | $69.97 | $18.47 |
| Indicator | TNXP | ASYS |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 64.29 |
| Support Level | $17.17 | $15.93 |
| Resistance Level | $18.75 | $18.47 |
| Average True Range (ATR) | 1.20 | 1.14 |
| MACD | 0.15 | 0.07 |
| Stochastic Oscillator | 43.98 | 63.62 |
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.